• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States.

作者信息

Lin Nancy U, Bichkoff Harvey, Hassett Michael J

机构信息

Dana-Farber Cancer Institute, Boston, MA; and Marin Cancer Care, Greenbrae, CA.

出版信息

J Oncol Pract. 2018 Sep;14(9):525-528. doi: 10.1200/JOP.18.00428. Epub 2018 Aug 20.

DOI:10.1200/JOP.18.00428
PMID:30125129
Abstract
摘要

相似文献

1
Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States.美国肿瘤护理交付中预先授权负担日益加重。
J Oncol Pract. 2018 Sep;14(9):525-528. doi: 10.1200/JOP.18.00428. Epub 2018 Aug 20.
2
Prior Authorization and the Cost of Health Care.预先授权与医疗保健成本。
J Foot Ankle Surg. 2019 Mar;58(2):201-202. doi: 10.1053/j.jfas.2019.01.008.
3
Prior Authorizations for Diagnostic Skin Biopsies: Does Anyone Benefit?诊断性皮肤活检的预先授权：有人从中受益吗？
JAMA Dermatol. 2017 Nov 1;153(11):1091-1092. doi: 10.1001/jamadermatol.2017.3516.
4
Evaluating the effect of prior authorizations in patients with complex dermatologic conditions.评估复杂皮肤科疾病患者的预授权的效果。
J Am Acad Dermatol. 2020 Dec;83(6):1674-1680. doi: 10.1016/j.jaad.2020.06.998. Epub 2020 Jul 2.
5
Prior authorization in gynecologic oncology: An analysis of clinical impact.妇科肿瘤学中的预先授权：临床影响分析
Gynecol Oncol. 2022 Dec;167(3):519-522. doi: 10.1016/j.ygyno.2022.10.002. Epub 2022 Oct 14.
6
Pharmacy resident involvement in prior-authorization drug request adjudication.药学住院医师参与事先授权药物申请的裁定。
Am J Health Syst Pharm. 2018 Dec 1;75(23 Supplement 4):S87-S93. doi: 10.2146/ajhp170431. Epub 2018 Sep 18.
7
Reducing the Burden of Medication Prior Authorizations.减轻药物预先授权的负担。
Fam Pract Manag. 2024 Sep;31(5):22-27.
8
Should health care systems become insurers?医疗保健系统应该成为保险公司吗？
JAMA. 2013 Oct 16;310(15):1561-2. doi: 10.1001/jama.2013.280015.
9
Burden with No Benefit: Prior Authorization in Congenital Cardiology.负担与无益：先天性心脏病的预先授权。
Pediatr Cardiol. 2024 Jan;45(1):100-106. doi: 10.1007/s00246-023-03255-1. Epub 2023 Sep 26.
10
The ethics of charging patients for prior authorizations.就预先授权向患者收费的伦理问题。
J Am Acad Dermatol. 2020 Jun;82(6):1574-1575. doi: 10.1016/j.jaad.2020.01.060. Epub 2020 Feb 1.

引用本文的文献

1
Patient Perspectives on Prior Authorization for Cancer Care.癌症护理预先授权的患者观点。
JAMA Netw Open. 2025 Jul 1;8(7):e2523807. doi: 10.1001/jamanetworkopen.2025.23807.
2
Prior Authorization and Association With Delayed or Discontinued Prescription Fills.事前授权与处方延迟或中断的关联。
J Clin Oncol. 2024 Mar 10;42(8):951-960. doi: 10.1200/JCO.23.01693. Epub 2023 Dec 12.
3
Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs.抗癌药物口服药获得时间与自费减免、保险类型、事先授权之间的关联。
JCO Oncol Pract. 2024 Jan;20(1):85-92. doi: 10.1200/OP.23.00205. Epub 2023 Nov 30.
4
Applications of Artificial Intelligence in Health Care Delivery.人工智能在医疗保健领域的应用。
J Med Syst. 2023 Nov 17;47(1):121. doi: 10.1007/s10916-023-02018-y.
5
The Patient Experience of Prior Authorization for Cancer Care.癌症治疗预先授权的患者体验。
JAMA Netw Open. 2023 Oct 2;6(10):e2338182. doi: 10.1001/jamanetworkopen.2023.38182.
6
Hepatopancreatobiliary malignancies: time to treatment matters.肝胰胆恶性肿瘤：治疗时机至关重要。
J Gastrointest Oncol. 2023 Apr 29;14(2):833-848. doi: 10.21037/jgo-22-1067. Epub 2023 Apr 17.
7
Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs.医疗机构专科药房与照护协调组织合作对口服抗肿瘤药物送达和接收时间的影响。
JCO Oncol Pract. 2023 Mar;19(3):e326-e335. doi: 10.1200/OP.22.00451. Epub 2022 Dec 6.
8
Strategic Operational Redesign for Successfully Navigating Prior Authorization Barriers at a Large-Volume Proton Therapy Center.大型质子治疗中心成功应对预先授权障碍的策略性运营重新设计。
JCO Oncol Pract. 2020 Oct;16(10):e1067-e1077. doi: 10.1200/JOP.19.00533. Epub 2020 Jul 8.
9
Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action.制定并维持一支高效且有韧性的肿瘤医护队伍：行动的机会。
J Natl Cancer Inst. 2020 Jul 1;112(7):663-670. doi: 10.1093/jnci/djz239.
10
Time to initial cancer treatment in the United States and association with survival over time: An observational study.美国癌症初始治疗时间与随时间变化的生存情况的关系：一项观察性研究。
PLoS One. 2019 Mar 1;14(3):e0213209. doi: 10.1371/journal.pone.0213209. eCollection 2019.